Judgment of the Court (Fourth Chamber) of 25 March 2021
H. Lundbeck A/S and Lundbeck Ltd v European Commission
Appeal – Competition – Agreements, decisions and concerted practices – Pharmaceutical products – Market for antidepressants (citalopram) – Settlement agreements relating to disputes concerning process patents concluded by a manufacturer of originator medicines who is the holder of those patents and manufacturers of generic medicines – Article 101 TFEU – Potential competition – Restriction by object – Characterisation – Calculation of the amount of the fine – Sales directly or indirectly related to the infringement
Case C-591/16 P
Reports of Cases
published in the electronic Reports of Cases (Court Reports - general)
Links to the texts
|
Curia |
EUR-Lex |
Autres Liens |
Opinion (C-591/16)
ECLI:EU:C:2020:428 |
|
|
|
Judgment
ECLI:EU:C:2021:243 |
|
|
|